Skip to main content

Table 4 Comparison of demographics and clinical features at baseline between patients with camptocormia and matched pairs groups when the disease duration < 5 years

From: Camptocormia in patients with multiple system atrophy at different disease durations: frequency and related factors

Variables Total With camptocormia Matched pairs P value
Number 92 29 63
Diagnosis (MSA-P/MSA-C) 50/42 17/12 33/30 0.577
Sex (male/female) 46/46 12/17 34/29 0.262
Age 62.30 ± 8.51 61.64 ± 7.53 62.61 ± 8.96 0.542
Age of onset 59.39 ± 8.47 58.63 ± 7.54 59.74 ± 8.91 0.427
Disease duration 2.91 ± 1.08 3.01 ± 1.01 2.87 ± 1.11 0.548
Educational year 10.13 ± 3.92 10.69 ± 4.31 9.87 ± 3.74 0.329
Onset symptoms
Autonomic symptom 36 12 24  
Cerebellar symptom 23 5 18  0.488
Parkinsonism symptom  33  12 21   
UMSARS-I 17.99 ± 6.70 18.72 ± 7.06 17.65 ± 6.56 0.495
UMSARS-II 20.59 ± 7.51 21.38 ± 8.65 20.22 ± 6.96 0.749
UMSARS-IV 2.58 ± 0.97 2.72 ± 1.16 2.51 ± 0.88 0.375
Total UMSARS score 41.15 ± 13.93 42.83 ± 15.94 40.38 ± 12.97 0.699
OH (yes/no) 28/64 9/20 19/44 0.932
Total score of FAB 14.27 ± 2.87 14.59 ± 2.90 14.13 ± 2.87 0.462
Total MOCA score 21.59 ± 5.18 22.10 ± 5.48 21.35 ± 5.07 0.365
HDRS score 12.65 ± 8.40 13.24 ± 8.58 12.38 ± 8.37 0.680
HARS score 10.41 ± 7.12 10.59 ± 6.75 10.33 ± 7.34 0.893
Disability (yes/no) 45/47 12/17 33/30 0.327
  1. MSA-P multiple system atrophy with predominately parkinsonism, MSA-C multiple system atrophy with predominately cerebellar ataxia, UMSARS unified multiple system atrophy rating scale, OH orthostatic hypotension, FAB frontal lobe battery, MoCA Montreal cognitive assessment, HDRS Hamilton depression rating scale, HARS Hamilton anxiety rating scale